Valuation Yabao Pharmaceutical Group Co., Ltd

Stocks

End-of-day quote Shanghai S.E. 29/10/2026			5-day change	1st Jan Change
7.100 ^CNY	-0.70%		+3.20%	+9.40%

10-27	Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
10-08	Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on July 31, 2026.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	3,835	6,992	4,528	5,215	4,385	4,491
Change	-	82.33%	-35.24%	15.19%	-15.93%	2.42%
Enterprise Value (EV) ¹	4,132	7,053	4,301	4,807	3,902	3,707
Change	-	70.7%	-39.02%	11.77%	-18.82%	-5%
P/E	35.7x	37.4x	43.3x	26.4x	18.1x	14.2x
PBR	1.38x	2.39x	1.52x	1.74x	1.49x	1.56x
PEG	-	0.5x	-1x	0.3x	0.6x	0.4x
Capitalization / Revenue	1.47x	2.53x	1.67x	1.79x	1.63x	2x
EV / Revenue	1.59x	2.55x	1.58x	1.65x	1.45x	1.65x
EV / EBITDA	14.4x	19.2x	12.7x	10.8x	9.45x	8.34x
EV / EBIT	35.2x	35.9x	24.1x	16.5x	14.1x	11.9x
EV / FCF	15.7x	25.5x	12.5x	13.4x	11.5x	9.22x
FCF Yield	6.36%	3.92%	8%	7.46%	8.7%	10.8%
Dividend per Share ²	0.05	0.08	0.05	0.15	0.3	0.35
Rate of return	1%	0.88%	0.85%	2.17%	4.93%	5.39%
EPS ²	0.1394	0.243	0.1359	0.2615	0.3356	0.4576
Distribution rate	35.9%	32.9%	36.8%	57.4%	89.4%	76.5%
Net sales ¹	2,602	2,764	2,718	2,910	2,686	2,240
EBITDA ¹	286.1	366.8	337.4	446.5	412.8	444.5
EBIT ¹	117.4	196.7	178.1	291.5	276.8	310.8
Net income ¹	107.4	187.1	104.7	199.6	242.7	320
Net Debt ¹	297.5	61.69	-226.9	-408.6	-482.9	-784.4
Reference price ²	4.980	9.080	5.880	6.900	6.090	6.490
Nbr of stocks (in thousands)	770,000	770,000	770,000	755,851	720,000	692,000
Announcement Date	4/23/21 A	4/27/22 A	4/25/23 A	4/25/24 A	4/25/25 A	4/24/26 A

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
YABAO PHARMACEUTICAL GROUP CO., LTD	-	-	-	-	742M
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	29.56x	7.11x	18.84x	2.11%	403.79B
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%